2:08 PM
 | 
Dec 09, 2016
 |  BC Week In Review  |  Clinical News  |  Clinical Results

CART-BCMA: Preliminary Ph I data

Preliminary data from 6 evaluable patients with relapsed or refractory MM in an open-label, U.S. Phase I trial showed that IV CART-BCMA over 3 days led to 1 stringent complete response, 1 very...

Read the full 141 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >